Dechra Pharmaceuticals PLC
19 July 2005
Dechra Pharmaceuticals PLC ('the Company')
Holding(s) in Company
The Company has been notified by Barclays PLC that through the legal entities of
Barclays Global Investors Ltd, Barclays Capital Securities Ltd and Barclays Life
Assurance Co Ltd, Barclays PLC has a notifiable interest in 2,057,814 ordinary
shares of 1p each in the Company ('Ordinary Shares'), representing approximately
4.02 per cent. of the Company's issued share capital. These Ordinary Shares are
registered as follows:
Registered Holder Ordinary Shares % of issued
share capital
Barclays Capital Nominees Limited 691,084 1.35
Chase Nominees Ltd a/c 16376 28,830 0.06
Chase Nominees a/c 21359 114,544 0.21
JP Morgan (BGI Custody) a/c 16341 34,116 0.07
JP Morgan (BGI Custody) a/c 16341 65,809 0.12
JP Morgan (BGI Custody) a/c 16344 23,844 0.05
JP Morgan (BGI Custody) a/c 16345 39,283 0.08
JP Morgan (BGI Custody) a/c 16400 371,257 0.73
JP Morgan (BGI Custody) a/c 16480 409,628 0.80
JP Morgan (BGI Custody) a/c 16482 250,007 0.49
JP Morgan (BGI Custody) a/c 18409 29,412 0.06
Total 2,057,814 4.02
19 July 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.